FDA Labeling Exemption For OTC Eye Drop Sought By Zee Medical

Zee Medical is asking for an exemption of certain labeling format and font requirements under FDA's OTC labeling final rule for the firm's Tetrahydrozoline Eye Drops product. The agency published the final rule March 17 ("The Tan Sheet" March 15, pp. 3-10).

More from Archive

More from Pink Sheet